Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.

Hosseini, Aref; Ghaedi, Kamran; Tanhaei, Somayeh; Ganjalikhani-Hakemi, Mazdak; Teimuri, Shohreh; Etemadifar, Masoud; Nasr Esfahani, Mohammad Hossein

Hosseini, Aref; Ghaedi, Kamran; Tanhaei, Somayeh; Ganjalikhani-Hakemi, Mazdak; Teimuri, Shohreh; Etemadifar, Masoud; Nasr Esfahani, Mohammad Hossein.

Afiliación

Hosseini A; Division of Cellular and Molecular Biology, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran.
Ghaedi K; Division of Cellular and Molecular Biology, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran; Department of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.
Tanhaei S; Department of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.
Ganjalikhani-Hakemi M; Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Teimuri S; Division of Cellular and Molecular Biology, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran.
Etemadifar M; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nasr Esfahani MH; Department of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.

Cell J ; 18(3): 371-80, 2016.

Article en En | MEDLINE | ID: mdl-27602319

Palabras clave

CD4+T-cell; MiR-223; MicroRNAs; Multiple Sclerosis; Th17

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell J Año: 2016 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google